Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings Article Swipe

View

Related Concepts

Medicine Palpitations Adverse effect Placebo Paroxysmal supraventricular tachycardia Dosing Tachycardia Anesthesia Randomized controlled trial Internal medicine Alternative medicine Pathology

James E. Ip , My Bui , A. John Camm , Benoit Coutu , Peter A. Noseworthy , Maria Leonor Parody , Samuel F. Sears , Narendra Kumar Singh , Juan Agudelo Uribe , John Vyselaar , Sarah Omodele , Silvia Shardonofsky , David B. Bharucha , Bruce S. Stambler ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1016/j.ahj.2024.01.007 · OA: W4391112980

Overall, these data will support the development of a potentially paradigm-changing long-term management strategy for recurrent PSVT.

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings Article Swipe

Related Topics